ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of section 122(3) of the Companies Act and paragraph 3.83(B) of the JSE listings requirements
APN 201903190043A
Notification in terms of section 122(3) of the Companies Act and paragraph 3.83(B) of the JSE listings requirements
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")
NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT
AND PARAGRAPH 3.83(b) OF THE JSE LISTINGS REQUIREMENTS
In accordance with section 122(3)(b) of the Companies Act, No. 71 of 2008 ("the Act") and paragraph
3.83(b) of the JSE Listings Requirements, holders of ordinary shares in the Company are advised
that Foord Asset Management (Pty) Limited has formally notified the Company that it has increased
its beneficial interest in the securities of the Company, which it holds on behalf of its clients, to
5.15% of the ordinary share capital of the Company, effective 19 March 2019.
Aspen will file the required notice with the Takeover Regulation Panel as required in terms of
section 122(3)(a) of the Act.
Durban
19 March 2019
Sponsor
Investec Bank Limited
Date: 19/03/2019 02:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
